Vimarsana
Biggest News Aggregation in the World

Page 8 - Peter Lio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Lio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Lio Today - Breaking & Trending Today

About 1 in 3 American Adults Has an Allergy - Vimarsana News

About 1 in 3 American Adults Has an Allergy

THURSDAY, Jan. 26, 2023 (HealthDay News) -- If it seems as though everyone you know struggles with some sort of allergy, new research suggests you are not mistaken.

How Finding the Right Doctor Changed My Eczema Treatment - Vimarsana News

How Finding the Right Doctor Changed My Eczema Treatment

Having a good relationship with your doctor is one of the most important aspects of the treatment you get ....

Source: webmd.com
Girl, 5, with eczema saw it clear up ten days after getting an injection - Vimarsana News

Girl, 5, with eczema saw it clear up ten days after getting an injection

Ariah Dhaliwal, from Illinois, was one of 162 preschoolers recruited to a clinical trial for new treatment Dupixent which could help eczema sufferers by calming their immune system.

Injections can reduce skin rashes and itches from severe eczema in children under 5, study finds - Vimarsana News

Injections can reduce skin rashes and itches from severe eczema in children under 5, study finds

Scientists at Northwestern University in Illinois , found the monoclonal antibody Dupilumab - sold under the brand name Dupixent - cut eczema symptoms by at least 75 percent in half of children.

Baricitinib Reduces Signs, Symptoms of Cyclosporine-Resistant AD - Vimarsana News

Baricitinib Reduces Signs, Symptoms of Cyclosporine-Resistant AD

Baricitinib 4 mg met the primary endpoint in a phase 3 study involving patients with AD who had failed or could not take cyclosporine.